The Journal of Immunology, Vol 152, Issue 6 2952-2959, Copyright © 1994 by American Association of Immunologists

ARTICLES

Membrane vesiculation of Naegleria fowleri amoebae as a mechanism for resisting complement damage

DM Toney and F Marciano-Cabral
Virginia Commonwealth University, Medical College of Virginia, Department of Microbiology and Immunology, Richmond 23298.

Pathogenic and nonpathogenic Naegleria amoebae activate the alternative C pathway; however, only pathogenic amoebae are resistant to C-mediated damage. The present study was undertaken to determine the mechanism by which highly pathogenic N. fowleri amoebae resist C-mediated damage. Nomarski optics microscopy and electron microscopy of Naegleria amoebae revealed membrane blebbing on the surface of C-resistant N. fowleri, but not on C-sensitive N. gruberi, in response to incubation in normal human serum diluted 1:4 to 1:16. Immunofluorescent staining of pathogenic amoebae, by using antiserum to human C proteins comprising the membrane attack complex, C5b through C9, and FITC-labeled goat anti- rabbit IgG, confirmed that the membrane attack complex was concentrated on the membrane blebs. Binding studies with the use of radioiodinated C9 demonstrated a decrease in the 125I-labeled C9 cpm associated with N. fowleri amoebae and an increase in the 125I-labeled C9 cpm associated with the released membrane vesicles after increasing incubation periods in normal human serum. Treatment of pathogenic, C- resistant N. fowleri with cytochalasin D or cytochalasin B to inhibit actin-dependent exocytic processes increased the susceptibility of the amoebae to C damage. In contrast, incubation of nonpathogenic, C- sensitive amoebae with cytochalasins did not alter their susceptibility to C lysis. These data indicate that pathogenic N. fowleri use membrane vesiculation to remove membrane-deposited C proteins, specifically the membrane attack complex (C5b-C9). The ability to remove surface- associated membrane attack complexes serves as one mechanism by which pathogenic N. fowleri resist C lysis.

This article has been cited by other articles:

				P. V. Beum, M. A. Lindorfer, F. Beurskens, P. T. Stukenberg, H. M. Lokhorst, A. W. Pawluczkowycz, P. W. H. I. Parren, J. G. J. van de Winkel, and R. P. Taylor Complement Activation on B Lymphocytes Opsonized with Rituximab or Ofatumumab Produces Substantial Changes in Membrane Structure Preceding Cell Lysis J. Immunol., July 1, 2008; 181(1): 822 - 832. [Abstract] [Full Text] [PDF]

				A. E. Fritzinger, D. M. Toney, R. C. MacLean, and F. Marciano-Cabral Identification of a Naegleria fowleri Membrane Protein Reactive with Anti-Human CD59 Antibody Infect. Immun., February 1, 2006; 74(2): 1189 - 1195. [Abstract] [Full Text] [PDF]

				X. W. Zhou, B. F. C. Kafsack, R. N. Cole, P. Beckett, R. F. Shen, and V. B. Carruthers The Opportunistic Pathogen Toxoplasma gondii Deploys a Diverse Legion of Invasion and Survival Proteins J. Biol. Chem., October 7, 2005; 280(40): 34233 - 34244. [Abstract] [Full Text] [PDF]

				P.-A. Cabanes, F. Wallet, E. Pringuez, and P. Pernin Assessing the Risk of Primary Amoebic Meningoencephalitis from Swimming in the Presence of Environmental Naegleria fowleri Appl. Envir. Microbiol., July 1, 2001; 67(7): 2927 - 2931. [Abstract] [Full Text] [PDF]